Drug Quality Focus On Asia, OTCs Supported By New US FDA Data

 
• By Bowman Cox

OTCs and other "no-application" products remain a drag on overall quality, agency finds in annual quality report, while India and China continue to pose challenges.

Compass needle pointing the blue text. Blue and black tones with blur effect and focus on the main word. Concept for quality assurance management.
drug quality suffered over the counter and across the sea

More from Manufacturing

More from Compliance